Now could be an opportune time to load up on some quality ASX 200 stocks according to one top broker.

According to a note out of Wilsons, its analysts believe that the recent market selloff has created an attractive risk/reward for Australian investors.

So, if you can stomach some volatility, then the stocks in this article could be worth considering. It said:

Following the pullback, the risk/reward of the ASX 200 has become increasingly attractive, with valuations now broadly in line with the historical average. However, we expect volatility to remain elevated over the near-term, with the prospect of tariffs remaining a market overhang until at least 2 April, when the US Department of Commerce is scheduled to release its comprehensive trade review.

Wilsons has highlighted a number of stocks to buy that feature in its Focus Portfolio. Let's see what they are:

Goodman Group (ASX: GMG)

This integrated industrial property giant could be an ASX 200 stock to buy according to the broker.

It highlights that its shares have pulled back meaningfully following a capital raising and the market selloff. Given its positive earnings outlook, it feels this has presented an opportunity for investors. It said:

GMG has pulled back largely due to last month's ~$4.4n capital raise to fund its data centre strategy. Notwithstanding the near-term equity dilution from the raise, GMG's EPS growth outlook remains attractive, underpinned by its data centre pipeline which will benefit from strong sector tailwinds from cloud migration and AI. We expect GMG to fund future developments with recycled capital (existing liquidity, retained earnings, equity sell-downs) and a modest amount of leverage

ResMed Inc. (ASX: RMD)

Another ASX 200 stock to get the thumbs up from Wilsons is sleep disorder treatment company ResMed.

It highlights that its shares have pulled back despite its strong second quarter update. The broker explains:

RMD has pulled back despite its strong Q2 EPS beat which drove consensus EPS upgrades. In the result management pointed to strong fundamentals as it highlighted 'once in a generation' tailwinds supporting CPAP demand over the medium-term (wearables, GLPs). At a PE of ~22x, RMD trades on a ~30% discount to its five-year average, which represents attractive value considering double-digit consensus EPS growth over the medium-term.

WiseTech Global Ltd (ASX: WTC)

Finally, this logistics solutions technology company could be cheap by historical standards according to the broker.

Commenting on the ASX 200 stock's significant decline, Wilsons said:

At a PE of ~60x, WTC trades at its lowest PE multiple in ~two years, offering highly attractive value on a growth-adjusted basis (3yr PEG of ~1.7x). WTC has pulled back following slight delays to the launch of Container Transport Optimisation (CTO). Despite the near-term downgrades, the medium/long-term earnings growth trajectory is broadly unchanged and remains attractive. WTC's 3 year EPS CAGR of >30% will be underpinned by 1) new customer wins, 2) large freight forwarder rollouts, and 3) the rollout of CTO (set to be launched initially in Australia in 2H25).